Status:
UNKNOWN
Rocket® Pleural Catheters: QOL, Feasibility and Satisfaction in Recurrent MPE Patients
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Malignant Pleural Effusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will take place in Ottawa, Ontario, and will include 100 patients who are receiving tunnelled pleural catheters to treat their symptoms of MPE. The aim of this study is to evaluate the effe...
Detailed Description
Pleural effusion is a medical condition, which occurs when too much fluid collects in the space between the lungs and the chest wall. This extra fluid makes it hard for the lungs to fully expand and t...
Eligibility Criteria
Inclusion
- Presence of symptomatic (BDI \< 6), and moderate sized (\> 1/3 of hemithorax) MPE
- Persistent malignant pleural effusion that is free flowing
- Life expectancy of at least 2 months (approximate duration of follow-up for the study)
- Age greater than 18
- Consent to undergoing TPC treatment for recurrent MPE
Exclusion
- Prior attempted chemical pleurodesis on ipsilateral side
- Active pleural or pulmonary infection
- Currently hospitalized for reasons other than MPE or in hospice care
- Life expectancy estimated at less than 2 months
- Inability to complete questionnaires (English or French)
- Refusal to give informed consent
- Pregnant women
Key Trial Info
Start Date :
March 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03403855
Start Date
March 7 2018
End Date
December 31 2021
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ottawa Hospital, General Campus
Ottawa, Ontario, Canada, K1H 8L6